A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s treatments. In a new study published in Nature Metabolism, researchers uncovered ...

In a new study published in Nature Metabolism titled “Neuronal Glycogen Breakdown Mitigates Tauopathy via Pentose Phosphate Pathway-Mediated Oxidative Stress Reduction,” researchers from the Buck ...

Scientists found that glycogen, a stored sugar in brain cells, helps manage oxidative stress through its metabolism and may slow the progression of Alzheimer’s disease, according to a study published ...

New research published in Nature Metabolism has identified a previously underestimated contributor to tau-related neurodegenerative conditions, including Alzheimer’s disease and frontotemporal ...

Researchers discover that glycogen and N-linked glycans accumulate in fibrotic regions of the lung and may be important for therapy development. Ramon Sun, a biochemist at the University of Florida ...

McArdle disease, also known as glycogen storage disease type V, is an inherited metabolic disorder marked by a deficiency of myophosphorylase, the enzyme essential for the breakdown of glycogen in ...

Researchers have made a breakthrough discovery that solves a mystery long forgotten by science and have identified a potentially novel avenue in pre-clinical models to treat non-small cell lung ...

A new study has identified an unexpected contributor to Alzheimer’s disease: glycogen, a complex sugar stored inside brain cells. While traditionally associated with muscles and the liver, glycogen ...

This is a preview. Log in through your library . Abstract Detection of glycogen in vivo would have utility in the study of normal physiology and many disorders. Presently, the only magnetic resonance ...

Optical densitometry (OD) of the cultures also indicated a dose-dependent rapid decrease in cell proliferation as revealed by the MTS assay (Figure 2). CP-320626 and 2-DOG-treated cultures showed ...

Scientists at the University of Kentucky Markey Cancer Center say they have made a discovery that solves a mystery and identified a potentially novel avenue in preclinical models to treat non-small ...